Furiex Pharmaceuticals, Inc. 4/A SEC Filings

Filed On	Filing
18 Sep 2013	Form 4/A: McIntyre Gail Frances, Senior Vice President-Research Sold 20,000 shares ($800K)
18 Sep 2013	Form 4/A: Corr Peter B, Director Received 3,600 shares by exercise or conversion ($32.8K) · Received 1,000 shares by exercise or conversion ($9.11K)
14 Mar 2013	Form 4/A: Kaldor Stephen W, Director Received 5,379 shares by exercise or conversion ($75K) · Sold 5,379 shares ($225K) · Received 973 shares by exercise or conversion ($13.6K) · 3 more
14 Mar 2013	Form 4/A: Ruscher Robert P, Director Received 23,565 shares by exercise or conversion ($269K) · Sold 23,565 shares ($984K) · Received 4,262 shares by exercise or conversion ($48.6K) · 3 more
11 Apr 2012	Form 4/A: Almenoff June Sherie, President Granted 10,368 Stock Options (to buy)
15 Mar 2012	Form 4/A: Eshelman Fredric N, Director Bought 75,000 shares ($1.63M)
07 Dec 2011	Form 4/A: Kaldor Stephen W, Director Granted 8,825 Stock Options (to buy)
07 Dec 2011	Form 4/A: Corr Peter B, Director Granted 8,825 Stock Options (to buy)
07 Dec 2011	Form 4/A: Dixon Wendy L, Director Granted 8,825 Stock Options (to buy)
07 Dec 2011	Form 4/A: Ruscher Robert P, Director Granted 8,825 Stock Options (to buy)
07 Dec 2011	Form 4/A: Bondurant Stuart, Director Granted 8,825 Stock Options (to buy)

Comments